Steven Cohen’s Ginkgo Bioworks DNA Stock Holding History

Steven Cohen’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76,908	Closed	-$639K	–	3932
2025 Q4	$639K	Buy	+76,908	New	+$828K	﹤0.01%	3117
2025 Q2	–	Sell	-73,100	Closed	-$417K	–	2288
2025 Q1	$417K	Sell	73,100 -26,700	-27%	-$272K	﹤0.01%	1675
2024 Q4	$980K	Buy	+99,800	New	+$855K	﹤0.01%	1462

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's DNA Position: Q1 2026 in Review

Steven Cohen sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 76,908 shares — an estimated $639K sold.

Steven Cohen first reported a position in DNA in Q4 2024 and held it in 3 quarters. The position peaked at $980K in Q4 2024. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Steven Cohen reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
Steven Cohen sold 76,908 Ginkgo Bioworks shares in Q1 2026, an estimated $639K.
Steven Cohen first reported a position in Ginkgo Bioworks in Q4 2024 and held it in 3 quarters.
Steven Cohen's Ginkgo Bioworks position peaked at $980K in Q4 2024.
175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.